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Cleft of the soft palate (CSP) and the hard palate (CHP) are subtypes of cleft palate. 
Patients with either condition often have difficulty with speech and swallowing. 
Nonsyndromic, cleft palate isolated has been reported to be associated with several 
genes, but to our knowledge there have been no detailed genetic investigations of CSP. 
We performed a genome-wide linkage analysis using an SNP-based microarray 
platform and successively using microsatellite markers in a family where six members, 
across three successive generations, had CSP. A maximum LOD score of 2.408 was 
obtained at 2p24.2–24.1 and 2p21–p12, assuming autosomal dominant inheritance. 
Our results suggest that either of these regions is responsible for this type of CSP. 
 




Orofacial cleft, one of the most common congenital malformations, is a 
heterogeneous group of complex traits. Orofacial cleft is classified into two main 
categories, cleft lip with or without cleft palate (CLP) and cleft palate isolated (CPI). 
Both clefting phenotypes can appear relating to some syndromes (syndromic orofacial 
cleft) or not relating to syndromes (nonsyndromic orofacial cleft). CPI is considered 
genetically distinct from CLP, based on epidemiological evidence and the different 
developmental timing of lip and palate formation. Recent molecular genetic studies1-4 
have identified genes or loci that are responsible for CPI. However, fewer genes and/or 
loci associated CPI have been reported in comparison with CLP. 5  
CPI is classified into mostly two subtypes morphologically: cleft of the hard palate 
(CHP) and cleft of the soft palate (CSP). 6 Submucous cleft palate (SMCP) is a small 
subgroup in the CPI. SMCP manifests with bifid uvula, separation of the muscle with 
an intact mucosa and a bony defect in the posterior edge of the hard palate.7 Both CHP 
and CSP are caused by a failure of fusion of the palatal shelves, but little is known 
what causes the difference in their phenotypes. Christensen et al. suggested that CHP 
and CSP might be etiologically distinct.9 Although the patients with CSP have serious 
problems in speech and deglutition as well as CHP, there have been no detailed genetic 
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studies performed. 
We recently encountered a Japanese family that included five CSP patients and one 
SMCP patient. The aim of this work was to identify the CSP/SMCP predisposing locus 
in this family using genome-wide single nucleotide polymorphism (SNP)-based 
linkage analysis. 
 
Materials and Methods 
Family and patients 
A Japanese family included five patients (I-2, II-2, II-3, III-1 and III-2) with CSP 
and one patient (II-5) with SMCP across three generations (Figure 1). Two patients 
(II-2 and II-3) were monozygotic twins. The phenotypes of two patients (III-1 and II-5) 
were shown in Figure 2. All the patients had no other symptoms such as mental 
retardation, and all family members were examined by one or two well-trained 
dentists. 
The disease in the family was consistent with an autosomal dominant mode of 
inheritance. Blood samples were obtained with written informed consent from 15 
co-operative family members (Figure 1). The study protocol was approved by the 




SNP genotyping and linkage analysis 
Genomic DNA was extracted from peripheral blood lymphocytes of the 15 members, 
using a QIAampTM DNA Mini Kit (QIAGEN, Hilden, Germany). Their genotypes were 
determined using a GeneChipTM Human Mapping 10K 2.0 Xba Array (Affymetrix, 
Santa Clara, CA). We used MERLIN software8 to analyze compiled pedigree data sets. 
Mendelian errors were detected by PEDCHECK,9 and SNPs with Mendelian error were 
not used in the data analysis. LOD scores were calculated under a parametric autosomal 
dominant model in which penetrance was set to 1.0 and disease allele frequency was 
0.00001. Since CSP and SMCP can be categorized together because of their similar 
anatomical features,10 the patient with SMCP (II-5) was classed as an “affected” as well 
as the patients with CSP for linkage score calculations. 
To confirm the result of the linkage data using GeneChipTM Human Mapping 10K 
2.0 Xba Array, we performed two point linkage analysis using microsatellite markers 
by the method described elsewhere.11 Two point LOD score was calculated using 
MLINK program. 12 
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Results and Discussion 
In the assay with the 10K-Array, the GeneChipTM call rates varied from 92.18 % to 
99.42 % (with a mean of 97.54 %). Two regions, 2p24.2–p24.1 (CSP region 1: CSPR1) 
a 4.5 Mb interval between rs1545497 and rs1872325, and 2p21–p12 (CSP region 2: 
CSPR2) a 34.5 Mb segment between rs940053 and rs310777, were CSP candidate loci 
with a maximum LOD score of 2.408 (Figure 3). The LOD scores of all other regions 
were below 1.000. Two point LOD scores using microsatellite markers showed same 
scores (2.408), therefore the result of linkage analysis from SNP genotyping was 
reconfirmed (haplotype using microsatellite markers was shown in Figure 1). It is thus 
likely that a gene playing a role in palatal fusion is located within either CSPR1 or 
CSPR2.  
Based on our knowledge of oral palate development, we chose nine genes from the 
candidate CSP regions and performed mutation analysis. Of the nine candidate genes, 
three were from CSPR1: growth/differentiation factor 7 (GDF7), matrilin 3 (MATN3) 
and member B of the Ras homolog gene family (RHOB). The other six genes were from 
CSPR2: calmodulin 2 (CALM2), bone morphologic protein 10 (BMP10), 
sprouty-related EVH1 domain-containing protein 2 (SPRED2), transforming growth 
factor, alfa (TGFA), ventral anterior homeobox 2 (VAX2; 2p13.3) and stoned B-like 
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factor / stonin 1 (STON1). Most of these genes are concerned with bone development, 
the TGF and mitogen-activated protein (MAP) kinase signaling pathways, or are 
transcription factors related to homeobox genes. However, no pathogenic mutation was 
found within any of its exons or intron/exon boundaries of all nine genes. 
To detect structural genomic alterations that may cause CSP within the candidate 
regions, we performed copy number analysis with the proband’s DNA using the 
Genome-Wide Human SNP Array 5.0 (Affymetrix). Although several copy-number 
alterations were detected (data was not shown), all were already registered as copy 
number variations on the UCSC Genome Browser (http://genome.ucsc.edu/) and none 
of them were coincided with regions with positive LOD scores. 
In conclusion, this is the first report of a whole-genome linkage analysis scan for 
CSP. Although the LOD scores calculated are not high enough to assign the disease 
locus definitively, our data suggest that it lies at either 2p24.2–24.1 or 2p21–p12. 
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Titles and legends to figures 
 
Figure 1. Family tree with haplotypes at 2p24.2–24.1 (CSPR1) and 2p21–p12 (CSPR2). 
Black closed, gray closed and open symbols indicate affected with cleft of the soft 
palate (CSP), affected with subcutaneous cleft palate (SMCP) and unaffected, 
respectively. An arrow indicates the proband. Genotypes of microsatellite markers 
defining the candidate intervals are shown below each individual. Boxed haplotype 
indicates possibly disease-associated haplotype.  
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Figure 2. Views of palates. The palate of individual III-1 with CSP (A) showing a cleft 
limited to the soft palate, and that of individual II-5 with SMCP (B) showing a 
translucent zone in the soft palate resulting from a separation of the muscle. 
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Figure 3. Multipoint LOD scores on chromosome 2. A 4.5 Mb (physical position, 
18281893–22775527) interval from rs1545497 to rs1872325 corresponds to CSPR1, 
and a 34.5 Mb interval (45834656–80355227) from rs940053 to rs310777 corresponds 
to CSPR2. 
